News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,020 Results
Type
Article (39150)
Company Profile (283)
Press Release (648587)
Section
Business (203903)
Career Advice (1996)
Deals (35372)
Drug Delivery (89)
Drug Development (80852)
Employer Resources (168)
FDA (16099)
Job Trends (14808)
News (344646)
Policy (32450)
Tag
Academia (2530)
Alliances (49186)
Alzheimer's disease (1262)
Approvals (16060)
Artificial intelligence (145)
Bankruptcy (352)
Best Places to Work (11582)
Biotechnology (200)
Breast cancer (189)
Cancer (1375)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (281)
Clinical research (64707)
Collaboration (485)
Compensation (262)
COVID-19 (2541)
C-suite (109)
Data (1391)
Diabetes (176)
Diagnostics (6170)
Earnings (84895)
Employer resources (146)
Events (110014)
Executive appointments (397)
FDA (16785)
Funding (431)
Gene therapy (195)
GLP-1 (599)
Government (4333)
Healthcare (18697)
Infectious disease (2634)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16344)
Job creations (3625)
Job search strategy (1418)
Layoffs (418)
Legal (7862)
Lung cancer (198)
Manufacturing (207)
Medical device (13213)
Medtech (13218)
Mergers & acquisitions (19195)
Metabolic disorders (460)
Neuroscience (1583)
NextGen Class of 2024 (6500)
Non-profit (4467)
Northern California (1700)
Obesity (262)
Opinion (183)
Parkinson's disease (98)
Patents (120)
People (56463)
Phase I (20127)
Phase II (28498)
Phase III (21240)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (264)
Real estate (5890)
Regulatory (21679)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1468)
Startups (3562)
United States (15234)
Vaccines (564)
Weight loss (182)
Date
Today (126)
Last 7 days (571)
Last 30 days (2374)
Last 365 days (35283)
2024 (35127)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37553)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (196)
Asia (37275)
Australia (6087)
California (3830)
Canada (1457)
China (307)
Colorado (172)
Connecticut (178)
Europe (79832)
Florida (537)
Georgia (136)
Illinois (387)
Indiana (225)
Maryland (634)
Massachusetts (2972)
Michigan (175)
Minnesota (291)
New Jersey (1108)
New York (1091)
North Carolina (743)
Northern California (1700)
Ohio (146)
Pennsylvania (928)
South America (1092)
Southern California (1468)
Texas (554)
Utah (108)
Washington State (401)
688,020 Results for "cutera inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Cutera, Inc. Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
Cutera, Inc. granted a total of 44,500 non-qualified inducement stock options to six employees.
May 30, 2024
·
1 min read
Business
Cutera Announces First Quarter 2024 Financial Results
Cutera, Inc., a leading provider of aesthetic and dermatology solutions, reported financial results for the first quarter ended March 31, 2024.
May 9, 2024
·
17 min read
Business
Cutera to Announce First Quarter Results on May 9, 2024
Cutera, Inc. today announced that it will report financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 9, 2024.
April 26, 2024
·
1 min read
Biotech Beach
Cutera® Announces the North America Launch of xeo®+
Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announces the launch of xeo+, a pioneering laser and light-based multi-application platform built on a rich history of excellence in performance and innovation.
April 11, 2024
·
3 min read
Biotech Bay
Cutera, Inc. Announces Preliminary Unaudited Financial Results for Full-Year 2023
Cutera, Inc., a leading provider of aesthetic and dermatology solutions, announced certain preliminary, unaudited financial results for the year ended December 31, 2023.
January 9, 2024
·
4 min read
Biotech Bay
Cutera, Inc. Reports Inducement Grants as permitted by the Nasdaq Listing Rules - November 16, 2023
Cutera, Inc., a leading provider of aesthetic and dermatology solutions, announced that Stephana Patton, who joined Cutera on November 13, 2023, as the Chief Legal Officer will receive a grant of inducement awards.
November 16, 2023
·
1 min read
Business
Cutera, Inc. to Announce Third Quarter Results on November 8, 2023
Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the third quarter of 2023 after the market close on Wednesday, November 8, 2023.
October 25, 2023
·
1 min read
Business
Cutera, Inc. Appoints Brent Hauser as President, International
Cutera, Inc. is pleased to announce the appointment of Brent Hauser as President, International, effective October 2, 2023.
October 2, 2023
·
3 min read
Biotech Bay
Cutera, Inc. to Participate in Upcoming Investor Conferences - November 10, 2023
Cutera, Inc. announced that Taylor Harris, Chief Executive Office, and Greg Barker, Vice President of Corporate FP&A and Investor Relations, will participate in Fireside Chats at the following upcoming investor conferences
November 10, 2023
·
1 min read
Business
Cutera to Announce Fourth Quarter and Full-Year 2023 Results on March 21, 2024
Cutera, Inc. today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023 after the market close on Thursday, March 21, 2024.
March 1, 2024
·
4 min read
1 of 68,802
Next
